EcoDrugPlus

Cytochrome P450, Family 19, Subfamily A, Polypeptide 1a

Ensembl ID : ENSCCRG00000012447
Gene Symbol: CYP19A1A
1 Cross references
251 Possible Orthologues:

Cytochrome P450, Family 19, Subfamily A, Polypeptide 1a

Ensembl ID : ENSCCRG00000033790
Gene Symbol: CYP19A1A
1 Cross references
251 Possible Orthologues:

Cytochrome P450, Family 26, Subfamily A, Polypeptide 1

Ensembl ID : ENSCCRG00000037048
Gene Symbol: CYP26A1
1 Cross references
192 Possible Orthologues:

Cytochrome P450, Family 26, Subfamily A, Polypeptide 1

Ensembl ID : ENSCCRG00000019654
Gene Symbol: CYP26A1
1 Cross references
192 Possible Orthologues:

Cytochrome P450, Family 3, Subfamily A, Polypeptide 65

Ensembl ID : ENSCCRG00000044727
Gene Symbol: CYP3A65
1 Cross references
595 Possible Orthologues:

Cytochrome P450, Family 3, Subfamily A, Polypeptide 65

Ensembl ID : ENSCCRG00000070397
Gene Symbol: CYP3A65
1 Cross references
597 Possible Orthologues:

Cytochrome P450, Family 3, Subfamily C, Polypeptide 4

Ensembl ID : ENSCCRG00000030874
Gene Symbol: CYP3C4
1 Cross references
555 Possible Orthologues:

Cytochrome P450, Family 3, Subfamily C, Polypeptide 4

Ensembl ID : ENSCCRG00000047631
Gene Symbol: CYP3C4
1 Cross references
558 Possible Orthologues:

Cytochrome P450, Family 46, Subfamily A, Polypeptide 1, Tandem Duplicate 3

Ensembl ID : ENSCCRG00000016055
Gene Symbol: CYP46A1.3
1 Cross references
257 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1a

Ensembl ID : ENSCCRG00000078368
Gene Symbol: DGAT1A
1 Cross references
188 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1a

Ensembl ID : ENSCCRG00000064682
Gene Symbol: DGAT1A
1 Cross references
188 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1b

Ensembl ID : ENSCCRG00000019769
Gene Symbol: DGAT1B
1 Cross references
184 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).